Biogen
BIIB
$230.04
Share price
-2.24%
Change (1 day)
-26.24%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Biogen (BIIB) - Total debt
Total debt on the balance sheet as of March 2024 : $6.94 B
According to Biogen's latest financial reports the company's total debt is $6.94 B. A company’s total debt is the sum of all current and non-current debts.
Biogen - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $7.33 B | 10.95% |
| 2022-12-31 | $6.61 B | -13.01% |
| 2021-12-31 | $7.60 B | -2.87% |
| 2020-12-31 | $7.82 B | 22.94% |
| 2019-12-31 | $6.36 B | 7.26% |
| 2018-12-31 | $5.93 B | -0.03% |
| 2017-12-31 | $5.93 B | -8.89% |
| 2016-12-31 | $6.51 B | -0.14% |
| 2015-12-31 | $6.52 B | 1018.67% |
| 2014-12-31 | $0.58 B | -2.1% |
| 2013-12-31 | $0.59 B | -47.77% |
| 2012-12-31 | $1.14 B | 7.21% |
| 2011-12-31 | $1.06 B | -11.59% |
| 2010-12-31 | $1.20 B | 9.42% |
| 2009-12-31 | $1.09 B | -1.18% |
| 2008-12-31 | $1.11 B | -28.78% |
| 2007-12-31 | $1.56 B | 1516.42% |
| 2006-12-31 | $96.69 M | 122.57% |
| 2005-12-31 | $43.44 M | -94.89% |
| 2004-12-31 | $0.85 B | -4.17% |
| 2003-12-31 | $0.88 B | 2.43% |
| 2002-12-31 | $0.86 B | 1735.76% |
| 2001-12-31 | $47.18 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 384.15% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 919.85% | 🇺🇸 USA |
 AbbVie ABBV | $59.38 B | 754.88% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 830.14% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 193.20% | 🇫🇷 France |
 Gilead Sciences GILD | $24.98 B | 259.70% | 🇺🇸 USA |
 Illumina ILMN | $2.26 B | -67.44% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.19 B | -97.25% | 🇺🇸 USA |
 Qiagen QGEN | $1.50 B | -78.36% | 🇳🇱 Netherlands |
 Bio-Rad Laboratories BIO | $1.40 B | -79.77% | 🇺🇸 USA |